The Industrifonden-led tranche has helped the Stockholm spinout lift the round to $13.3m, which will be used to conduct a proof-of-concept run.

EnginZyme, a Sweden-based enzyme technology spinout of Stockholm University, has secured a series A extension led by government-backed venture capital firm Industrifonden, increasing the round to €11m ($13.3m). SEB Greentech VC, a clean energy-focused vehicle for financial services group SEB, also took part, as did unnamed returning investors. The company had completed a $6.9m close…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.